Down-Regulation of Insulin Like Growth Factor 1 Involved in Alzheimer's Disease via MAPK, Ras, and FoxO Signaling Pathways

The inability to halt or even delay the course of Alzheimer's disease (AD) forces the development of new molecular signatures and therapeutic strategies. Insulin like growth factor 1 (IGF1) is a promising target for AD treatment, yet exact mechanisms of AD ascribed to IGF1 remain elusive. Herei...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Kexin, Bai, Jun, Zhong, Shanshan, Zhang, Rongwei, Zhang, Xiaoqian, Xu, Ying, Zhao, Mei, Zhao, Chuansheng, Zhou, Zhike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096571/
https://www.ncbi.nlm.nih.gov/pubmed/35571248
http://dx.doi.org/10.1155/2022/8169981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096571/
https://www.ncbi.nlm.nih.gov/pubmed/35571248
http://dx.doi.org/10.1155/2022/8169981

Ejemplares similares